Matches in Nanopublications for { ?s ?p "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294604.RAT4hShx3CPowOpKOrJvJy-7ostFi8Pv55xdssPd4lFp4130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294604.RAT4hShx3CPowOpKOrJvJy-7ostFi8Pv55xdssPd4lFp4130_provenance.
- NP1294609.RAeiwXHJfaeTiUPNiBAllwO9grOPl9mpVZMoCAqEKMF2k130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294609.RAeiwXHJfaeTiUPNiBAllwO9grOPl9mpVZMoCAqEKMF2k130_provenance.
- NP1294603.RAEoPZV1s3KUtkxyZfsBIaiv2_ERDcoOtYxjlzkaWvSgE130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294603.RAEoPZV1s3KUtkxyZfsBIaiv2_ERDcoOtYxjlzkaWvSgE130_provenance.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.
- NP1294602.RA9EWYPYBJ4sLyL0NI9_6LH0LIImgC3uUedMvfX7YzVYo130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294602.RA9EWYPYBJ4sLyL0NI9_6LH0LIImgC3uUedMvfX7YzVYo130_provenance.
- NP1294606.RAxvIA5UKkk8pTCx2Sw0yrcUn664kBOA4e-SX7PWZ40E4130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294606.RAxvIA5UKkk8pTCx2Sw0yrcUn664kBOA4e-SX7PWZ40E4130_provenance.